Acetylstaurosporine
| Internal ID | 80873059-6d1f-467f-b16e-9a11c8f1fcbb |
| Taxonomy | Organoheterocyclic compounds > Indoles and derivatives > Carbazoles > Pyrrolocarbazoles > Indolocarbazoles |
| IUPAC Name | N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylacetamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C30H28N4O4/c1-15(35)32(3)21-13-22-33-19-11-7-5-9-16(19)24-25-18(14-31-29(25)36)23-17-10-6-8-12-20(17)34(27(23)26(24)33)30(2,38-22)28(21)37-4/h5-12,21-22,28H,13-14H2,1-4H3,(H,31,36)/t21-,22-,28-,30+/m1/s1 |
| InChI Key | GRENHRYHWHSBLM-OCGXLOOESA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C30H28N4O4 |
| Molecular Weight | 508.60 g/mol |
| Exact Mass | 508.21105539 g/mol |
| Topological Polar Surface Area (TPSA) | 77.70 Ų |
| XlogP | 3.20 |
| Atomic LogP (AlogP) | 4.61 |
| H-Bond Acceptor | 6 |
| H-Bond Donor | 1 |
| Rotatable Bonds | 2 |
| 4'-N-Acetylstaurosporine |
| F6LFT9F3UZ |
| CHEMBL4764299 |
| 2173322-11-5 |
| Acetamide, N-((9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-11-yl)-N-methyl- |
| N-((9S,10R,11R,13R)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-11-yl)-N-methylacetamide |
| UNII-F6LFT9F3UZ |
| SCHEMBL22765529 |
| BDBM50547709 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7144 | 71.44% |
| Caco-2 | - | 0.6972 | 69.72% |
| Blood Brain Barrier | + | 0.7250 | 72.50% |
| Human oral bioavailability | - | 0.5000 | 50.00% |
| Subcellular localzation | Lysosomes | 0.5478 | 54.78% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8759 | 87.59% |
| OATP1B3 inhibitior | + | 0.9326 | 93.26% |
| MATE1 inhibitior | - | 0.7200 | 72.00% |
| OCT2 inhibitior | - | 0.8359 | 83.59% |
| BSEP inhibitior | + | 0.9748 | 97.48% |
| P-glycoprotein inhibitior | + | 0.8895 | 88.95% |
| P-glycoprotein substrate | + | 0.8981 | 89.81% |
| CYP3A4 substrate | + | 0.7281 | 72.81% |
| CYP2C9 substrate | - | 0.5712 | 57.12% |
| CYP2D6 substrate | - | 0.8782 | 87.82% |
| CYP3A4 inhibition | - | 0.5938 | 59.38% |
| CYP2C9 inhibition | - | 0.6041 | 60.41% |
| CYP2C19 inhibition | - | 0.7036 | 70.36% |
| CYP2D6 inhibition | - | 0.9313 | 93.13% |
| CYP1A2 inhibition | - | 0.7245 | 72.45% |
| CYP2C8 inhibition | + | 0.6821 | 68.21% |
| CYP inhibitory promiscuity | - | 0.5236 | 52.36% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.6052 | 60.52% |
| Eye corrosion | - | 0.9894 | 98.94% |
| Eye irritation | - | 0.9587 | 95.87% |
| Skin irritation | - | 0.7993 | 79.93% |
| Skin corrosion | - | 0.9411 | 94.11% |
| Ames mutagenesis | + | 0.6300 | 63.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.8164 | 81.64% |
| Micronuclear | + | 0.7800 | 78.00% |
| Hepatotoxicity | + | 0.6539 | 65.39% |
| skin sensitisation | - | 0.8966 | 89.66% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.9333 | 93.33% |
| Mitochondrial toxicity | + | 0.7875 | 78.75% |
| Nephrotoxicity | + | 0.5303 | 53.03% |
| Acute Oral Toxicity (c) | III | 0.6212 | 62.12% |
| Estrogen receptor binding | + | 0.7925 | 79.25% |
| Androgen receptor binding | + | 0.6638 | 66.38% |
| Thyroid receptor binding | + | 0.6484 | 64.84% |
| Glucocorticoid receptor binding | + | 0.8553 | 85.53% |
| Aromatase binding | + | 0.6690 | 66.90% |
| PPAR gamma | + | 0.6954 | 69.54% |
| Honey bee toxicity | - | 0.6673 | 66.73% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | + | 0.5100 | 51.00% |
| Fish aquatic toxicity | - | 0.4808 | 48.08% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2708 | Q16584 | Mitogen-activated protein kinase kinase kinase 11 | 99.36% | 81.14% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 99.12% | 85.14% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.09% | 91.11% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.79% | 96.09% |
| CHEMBL4924 | Q9UK32 | Ribosomal protein S6 kinase alpha 6 | 98.58% | 80.00% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 98.03% | 80.71% |
| CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 | 97.99% | 95.64% |
| CHEMBL4598 | Q13043 | Serine/threonine-protein kinase MST1 | 97.48% | 96.64% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 97.19% | 83.10% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 96.97% | 85.11% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 96.93% | 89.00% |
| CHEMBL5408 | Q9UHD2 | Serine/threonine-protein kinase TBK1 | 96.86% | 90.48% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.66% | 94.45% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 96.52% | 88.81% |
| CHEMBL3788 | O00444 | Serine/threonine-protein kinase PLK4 | 96.49% | 83.65% |
| CHEMBL5284 | Q96RR4 | CaM-kinase kinase beta | 96.41% | 89.23% |
| CHEMBL2581 | P07339 | Cathepsin D | 96.41% | 98.95% |
| CHEMBL2801 | Q13557 | CaM kinase II delta | 96.16% | 84.49% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 95.39% | 95.56% |
| CHEMBL1974 | P36888 | Tyrosine-protein kinase receptor FLT3 | 94.78% | 91.83% |
| CHEMBL5678 | P34947 | G protein-coupled receptor kinase 5 | 94.61% | 88.00% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 94.04% | 80.00% |
| CHEMBL4599 | Q07912 | Tyrosine kinase non-receptor protein 2 | 93.81% | 94.29% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 93.65% | 87.16% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 93.04% | 90.08% |
| CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 92.94% | 81.58% |
| CHEMBL1868 | P17948 | Vascular endothelial growth factor receptor 1 | 92.45% | 96.47% |
| CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET | 92.33% | 91.79% |
| CHEMBL4237 | O75582 | Ribosomal protein S6 kinase alpha 5 | 92.21% | 91.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 91.29% | 95.89% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 90.42% | 90.95% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 90.23% | 94.00% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 90.12% | 98.59% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 90.10% | 93.03% |
| CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 88.79% | 96.00% |
| CHEMBL5314 | Q06418 | Tyrosine-protein kinase receptor TYRO3 | 88.70% | 96.00% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 88.08% | 99.23% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 88.08% | 91.03% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 87.91% | 95.83% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 87.34% | 86.33% |
| CHEMBL4224 | P49759 | Dual specificty protein kinase CLK1 | 87.28% | 85.30% |
| CHEMBL2716 | Q8WUI4 | Histone deacetylase 7 | 87.17% | 89.44% |
| CHEMBL3820 | P35557 | Hexokinase type IV | 86.83% | 91.96% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 86.60% | 97.14% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 86.28% | 91.07% |
| CHEMBL2535 | P11166 | Glucose transporter | 86.04% | 98.75% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 85.42% | 88.56% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 84.44% | 90.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 84.40% | 97.09% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 82.97% | 82.50% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 82.90% | 93.00% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 81.88% | 95.36% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 81.28% | 91.19% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 81.19% | 97.25% |
| CHEMBL2527 | O96017 | Serine/threonine-protein kinase Chk2 | 81.04% | 97.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 101644397 |
| LOTUS | LTS0127888 |
| wikiData | Q105015832 |